|
| | Cefuzonam Basic information |
| Product Name: | Cefuzonam | | Synonyms: | CEFUZONAM;(6r,7s)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-3-(thiadiazol-5-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-3-[(5-thiadiazolylthio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;Cefuzonam sodium;1-[[(6r,7r)-7-[[(2z)-(5-amino-1,2,4-thiadiazol-3-yl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-imidazo[1,2-b]pyridazinium hydroxide inner salt;CL-251931;CZON;L-105【Cephem antibiotic】 | | CAS: | 82219-78-1 | | MF: | C16H15N7O5S4 | | MW: | 513.59 | | EINECS: | | | Product Categories: | | | Mol File: | 82219-78-1.mol |  |
| | Cefuzonam Chemical Properties |
| Toxicity | LD50 in female, male mice, female, male rats (mg/kg): 4117, >4800, 4281, 4222 i.v.; 6424, 6783, >8000, >8000 i.p.; all >10000 orally (Takita) |
| | Cefuzonam Usage And Synthesis |
| Description | Cefuzonam is an injectable cephalosporin reported to be active against a large percentage
of Gram-negative bacteria and some Gram-positive bacteria, including those resistant to
other third-generation cephdosporins. | | Originator | Lederle (USA) | | Definition | ChEBI: A second generation cephalosporin antibiotic. | | Brand name | Cosmosin |
| | Cefuzonam Preparation Products And Raw materials |
|
